tiprankstipranks
Advertisement
Advertisement

PCXELTI Stock Latest News

Xeltis Builds Clinical Momentum and Commercial Bench Strength Around aXess Hemodialysis Conduit
Private CompaniesXeltis Builds Clinical Momentum and Commercial Bench Strength Around aXess Hemodialysis Conduit
1d ago
XELTI
Xeltis Highlights Pivotal aXess Data and Clinical Engagement at VASA 2026
PremiumPrivate Companies
Xeltis Highlights Pivotal aXess Data and Clinical Engagement at VASA 2026
3d ago
XELTI
Clinical Data and U.S. Program Activity Highlight Progress for Xeltis aXess
PremiumPrivate Companies
Clinical Data and U.S. Program Activity Highlight Progress for Xeltis aXess
3d ago
XELTI
Xeltis Strengthens Commercial Leadership Following CE Mark for aXess Hemodialysis Conduit
PremiumPrivate Companies
Xeltis Strengthens Commercial Leadership Following CE Mark for aXess Hemodialysis Conduit
4d ago
XELTI
Xeltis Strengthens Commercial Leadership Following CE Mark for aXess Vascular Access Conduit
PremiumPrivate Companies
Xeltis Strengthens Commercial Leadership Following CE Mark for aXess Vascular Access Conduit
5d ago
XELTI
Clinical Momentum Builds Around Xeltis aXess Hemodialysis Conduit
PremiumPrivate CompaniesClinical Momentum Builds Around Xeltis aXess Hemodialysis Conduit
5d ago
XELTI
Clinical Momentum Builds Around Xeltis aXess Hemodialysis Conduit
Premium
Private Companies
Clinical Momentum Builds Around Xeltis aXess Hemodialysis Conduit
5d ago
XELTI
Xeltis Steps Up Clinical Spotlight on aXess With Dual Kidney Disease Forum Push
Premium
Private Companies
Xeltis Steps Up Clinical Spotlight on aXess With Dual Kidney Disease Forum Push
8d ago
XELTI
Xeltis Highlights Clinical Progress of aXess at Upcoming VASA 2026 Symposium
PremiumPrivate Companies
Xeltis Highlights Clinical Progress of aXess at Upcoming VASA 2026 Symposium
9d ago
XELTI
Xeltis Showcases aXess Clinical Progress at 2026 VASA Dialysis Symposium
PremiumPrivate Companies
Xeltis Showcases aXess Clinical Progress at 2026 VASA Dialysis Symposium
10d ago
XELTI
Xeltis Highlights aXess Clinical Data at Global Kidney Disease Innovation Summit
PremiumPrivate Companies
Xeltis Highlights aXess Clinical Data at Global Kidney Disease Innovation Summit
11d ago
XELTI
Xeltis Highlights Hemodialysis Vascular Access Data at Kidney Disease Innovation Summit
PremiumPrivate Companies
Xeltis Highlights Hemodialysis Vascular Access Data at Kidney Disease Innovation Summit
12d ago
XELTI
Xeltis Moves Toward European Commercial Launch After CE Mark for aXess Vascular Access Device
PremiumPrivate CompaniesXeltis Moves Toward European Commercial Launch After CE Mark for aXess Vascular Access Device
22d ago
XELTI
Xeltis Highlights Pivotal EU Trial Data for aXess Vascular Access Conduit
Premium
Private Companies
Xeltis Highlights Pivotal EU Trial Data for aXess Vascular Access Conduit
24d ago
XELTI
Xeltis Highlights aXess Pivotal Trial Data and Clinician Interest in Regenerative Vascular Access
Premium
Private Companies
Xeltis Highlights aXess Pivotal Trial Data and Clinician Interest in Regenerative Vascular Access
25d ago
XELTI
Xeltis Secures CE Mark for aXess and Shifts Toward European Commercial Rollout
PremiumPrivate Companies
Xeltis Secures CE Mark for aXess and Shifts Toward European Commercial Rollout
29d ago
XELTI
Xeltis Showcases aXess Dialysis Access Technology at German Clinical Symposium
PremiumPrivate Companies
Xeltis Showcases aXess Dialysis Access Technology at German Clinical Symposium
1M ago
XELTI
Xeltis Showcases aXess Vascular Access Technology at Dialysis Symposium
PremiumPrivate Companies
Xeltis Showcases aXess Vascular Access Technology at Dialysis Symposium
1M ago
XELTI
Xeltis Advances CE-Marked Vascular Access Device Toward European Commercialization
PremiumPrivate Companies
Xeltis Advances CE-Marked Vascular Access Device Toward European Commercialization
1M ago
XELTI
Xeltis Advances aXess Vascular Access Device Toward European Commercialization After CE Mark
PremiumPrivate CompaniesXeltis Advances aXess Vascular Access Device Toward European Commercialization After CE Mark
1M ago
XELTI
Xeltis Prepares European Commercialization of aXess After Pivotal Trial Data
Premium
Private Companies
Xeltis Prepares European Commercialization of aXess After Pivotal Trial Data
1M ago
XELTI
Xeltis Gains CE Mark for aXess Dialysis Access Device, Paving Way to Commercial Stage
Premium
Private Companies
Xeltis Gains CE Mark for aXess Dialysis Access Device, Paving Way to Commercial Stage
1M ago
XELTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >